Pharmacogenomics is the study of a person's genetic structure, or genome, to determine which treatments and drug doses are most likely to work for that individual. This emerging field blends pharmacology, the science of how medications operate, with genomics, the science of the human genome. Precision medicine attempts to personalize health care in every manner possible, with choices and treatments suited to each individual. Precision medicine includes pharmacogenomics. Pharmacogenetics and pharmacogenomics are terms that can be interchanged. Pharmacogenomics, on the other hand, refers to the entire set of genes involved in determining therapeutic efficacy and safety, whereas pharmacogenetics refers to monogenetic variations that modify drug response. In terms of advances in human genomic science, pharmacogenetics is suggested as a key clinically proven application.
Title : Copper (II) complexes as potential anticancer agents
Salah S Massoud, University of Louisiana, United States
Title : Pharmacogenomics: current status and future directions
Matthias Schwab, University of Tübingen, Germany
Title : Talus bone of the hindfoot: Unique anatomy and an important clinical implication
Abdelmonem Awad Hegazy, Zarqa University, Jordan
Title : The use of anti seizure medication therapeutic blood level determination to personalise the treatment of epileptic seizures especially in patients attending the accident and emergency department
Roy Gary Beran, University of New South Wales, Australia
Title : Effect of Fluvoxamine on Interluekin-6 level of COVID-19 patients, hospitalized in ICU: A randomized clinical trial
Mitra Safa, Shahid Beheshti University of Medical Sciences, Iran (Islamic Republic of)
Title : Precision Treatment of Alzheimer's
Boris Tankhilevich, Magtera, Inc., United States